Secondly, a key problem with Sun et al. ' s transformation in practice is that such a transformation is marker-specific. Namely, when performing a GWAS, one needs to transform the phenotypic records differently for different markers, according to the phenotypic distribution across the genotypes per marker. This does not make much sense in practical analyses, because if there is a "best" scale of the phenotype, it should be used for all the markers across the genome, before testing the association between the phenotype and the markers. Using the tested marker to determine the transformation of the phenotype is strange. If a marker-specific transformation can be estimated, one should estimate a genome-specific transformation for GWAS, instead of doing different transformations marker-by-marker.
Thirdly, if the transformation of the phenotype is determined by one marker showing a significant effect on the phenotypic variability before testing the other markers, another significant effect on the phenotypic variability might be created due to such a transformation. In such a situation, it is problematic to decide which phenotypic scale we should choose.
Fourthly, several recent studies discussed that gene-gene or geneenvironment interactions could cause significant variance heterogeneity across genotypes [3] [4] [5] [6] , which makes testing variance-controlling loci a powerful tool to reveal potential interaction effects. Reducing the difference in variance across genotypes using a marker-specific variance-stabilization transformation would dramatically reduce such power. Regarding the biological sense of genetically regulated variance heterogeneity, empirical evidence has shown that a single causal locus could show a much higher significant effect on variance compared with the mean 6 . In a particular population, such a locus may only be mappable through testing the variability rather than the magnitude of the phenotype.
The above issues cause us to question Sun et al.'s transformation in practice. The scale of the phenotype is certainly an important concern when interpreting an effect on phenotypic variability 7 . However, one needs to be careful for the points above before applying any transformation on the data. In particular, the statistical power in detecting functional loci and the real meaning of the scale used should be emphasized.
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The authors declare no competing interest. We agree with criticism raised by Shen and Ronnegard in their points 2 and 3 concerning the application of the transformation of Sun . in the context of whole-genome scans. Indeed, applying this et al transformation in SNP-specific manner is difficult to adopt conceptually. Sun rightly suggest that "the et al. scales on which we measure interval-scale quantitative traits are man-made and have little intrinsic biological relevance", but the underlying intrinsic scale, and the function reflecting this scale into the observed, is likely to be unique and does not change with SNP. In that, the transformation applied to a trait should not change through the markers studied. Practically, this is not very difficult to implement, and as a simplest option one could think of the estimation of Sun's transformation parameters from upper, middle and lower tertiles of the total phenotypic distribution. A more general approach (without restricting the data into three groups, but modelling the variance as a function of the mean) should be straightforward to implement.
We also understand the reasoning behind the Shen and Ronnegard's points 1 and 4, but here we are less certain that the problem raised could be easily addressed. Specifically, one could argue with point 1 ("why should we regard the difference between 160cm and 170cm different from 170cm and 180cm?"): it is not that hard to imagine a biologically relevant model in which same changes of an "intrinsic scale" lead to different changes on the observed scale as the mean advances (an example would be Michaelis-Menten kinetics). Also both points 1 and 4 (losing power after transformation) relate not only to Sun .'s et al transformation, but to almost any transformation in wide use (e.g. Log, Box-Cox, Gaussenization/inverse-normal). While it is true that analysis of transformed trait may lead to reduced power (and specifically in case of Sun's transformation applied in marker-specific manner to the analysis of variance heterogeneity it ), we have a feeling that one still would like to check whether the should variance heterogeneity found can be modeled as a function of the mean (in which case any SNP affecting the mean is likely to show "control" of the variance as well).
Finally, we fully agree with comment of William Hill and Ian White who criticize Sun .'s statement that et al "'In the absence of genotypic mean differences, we can hardly infer that differences in variances are per of biological interest". We think that the differences in variance are biologically and genetically se per se plausible and interesting.
We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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No competing interests were disclosed. Sun . published in et al AJHG which advocates that, before any claim of differences in variance among genotypes in a GWAS or similar study, a check should first be made whether these can be removed by a monotonic transformation. Each of SR's four criticisms seems well justified.
As 105 or more SNPs may be fitted in a GWAS study, what biological interpretation could be given to that number of different transformations or even on a limited subset of loci showing possible variance differences? If some loci give signals of mean but not variance difference, should these then be transformed to eliminate the scale effect on mean and perhaps reveal variance differences? Any concept of an original scale of measurement is lost, as SR point out. It is not obvious why the mere existence of a transformation designed to minimise differences in variance should prevent discussion of variance heterogeneity on the chosen scale. Equivalently, if we considered means of the three genotypes at the locus rather than just average effects, would our ability to transform the data at each locus such that heterozygotes were intermediate imply there was no dominance, or only that it was on a particular scale?
On a further point. Sun . (p395) comment: 'In the absence of genotypic mean differences, we can et al hardly infer that differences in variances are of biological interest.' That is to take too narrow a view: per se the mean and phenotypic variance (or CV) of a quantitative trait in any species take typical values, e.g. the CV for adult human height is ca. 4% and for BMI ca. 16% . There is direct evidence of genetic differences within species in environmental variance, with GWAS and other single gene studies, that cannot be removed by scale, so the level of the environmental variance is subject to evolutionary forces (e.g.
).
To view variance as a biological phenomenon which is just Hill & Mulder 2010 Genet. Res. 92:381 some adjunct to the mean seems simplistic, as SR argue. Indeed one has to ask whether scale transformations have value unless there is a biological basis, such as a log transformation to account for multiplicative genetic effects; but that must then apply across all loci.
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